Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31


Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.

Bohmwald K, Espinoza JA, Pulgar RA, Jara EL, Kalergis AM.

Front Immunol. 2017 Nov 27;8:1643. doi: 10.3389/fimmu.2017.01643. eCollection 2017. Review.


Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Griffiths C, Drews SJ, Marchant DJ.

Clin Microbiol Rev. 2017 Jan;30(1):277-319. Review.


Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.

Larios Mora A, Detalle L, Van Geelen A, Davis MS, Stohr T, Gallup JM, Ackermann MR.

PLoS One. 2015 Dec 7;10(12):e0143580. doi: 10.1371/journal.pone.0143580. eCollection 2015.


Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE Jr, Hennessey JP Jr.

Front Immunol. 2014 Sep 26;5:463. doi: 10.3389/fimmu.2014.00463. eCollection 2014. Review.


Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.

Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA.

PLoS One. 2013 Sep 10;8(9):e74905. doi: 10.1371/journal.pone.0074905. eCollection 2013.


Respiratory syncytial virus infection: from biology to therapy: a perspective.

Mohapatra SS, Lockey RF.

World Allergy Organ J. 2008 Feb;1(2):21-8. doi: 10.1097/WOX.0b013e31816549a2.


Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats.

Smith G, Raghunandan R, Wu Y, Liu Y, Massare M, Nathan M, Zhou B, Lu H, Boddapati S, Li J, Flyer D, Glenn G.

PLoS One. 2012;7(11):e50852. doi: 10.1371/journal.pone.0050852. Epub 2012 Nov 30.


Impact of respiratory syncytial virus: the nurse's perspective.

Bracht M, Basevitz D, Cranis M, Paulley R.

Drugs R D. 2011 Sep 1;11(3):215-26. doi: 10.2165/11593140-000000000-00000. Review.


Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.

Empey KM, Peebles RS Jr, Kolls JK.

Clin Infect Dis. 2010 May 1;50(9):1258-67. doi: 10.1086/651603. Review.


Respiratory syncytial virus vaccine: Is it coming?

Sales V, Wang EE.

Paediatr Child Health. 2003 Dec;8(10):605-8.


RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.

Wu H, Dennis VA, Pillai SR, Singh SR.

Virus Res. 2009 Oct;145(1):39-47. doi: 10.1016/j.virusres.2009.06.012. Epub 2009 Jun 21.


Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.

Singh SR, Dennis VA, Carter CL, Pillai SR, Jefferson A, Sahi SV, Moore EG.

Vaccine. 2007 Aug 14;25(33):6211-23. Epub 2007 Jun 26.


Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.

Lee S, Miller SA, Wright DW, Rock MT, Crowe JE Jr.

J Virol. 2007 Mar;81(5):2349-58. Epub 2006 Dec 20.


Vaccines: all things considered.

Rosenthal KS, Zimmerman DH.

Clin Vaccine Immunol. 2006 Aug;13(8):821-9. Review. No abstract available.


Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants.

Markov PV, Crowcroft NS.

Epidemiol Infect. 2007 Jan;135(1):17-26. Epub 2006 Jun 2.


Modelling hospital admissions for lower respiratory tract infections in the elderly in England.

Müller-Pebody B, Crowcroft NS, Zambon MC, Edmunds WJ.

Epidemiol Infect. 2006 Dec;134(6):1150-7. Epub 2006 May 26. Review.


Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.

Valosky J, Hishiki H, Zaoutis TE, Coffin SE.

Clin Diagn Lab Immunol. 2005 Jan;12(1):171-9.


Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.

Tang RS, MacPhail M, Schickli JH, Kaur J, Robinson CL, Lawlor HA, Guzzetta JM, Spaete RR, Haller AA.

J Virol. 2004 Oct;78(20):11198-207.


Supplemental Content

Support Center